Recent CWBR News
- CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) • Business Wire • 11/27/2023 11:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 10:21:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:05:22 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 01:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:42 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/06/2023 08:13:20 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:11:18 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2023 01:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 01:12:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2023 04:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2023 08:47:59 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 05:44:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:07:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:05:38 PM
- CohBar Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/14/2023 08:01:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/10/2023 09:30:56 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • GlobeNewswire Inc. • 06/05/2023 12:05:22 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/30/2023 12:05:15 PM
- CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy • GlobeNewswire Inc. • 05/23/2023 11:30:39 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM